Graco Inc. v. Carlisle Construction Materials, LLC

District Court, D. Delaware·Decided October 7, 2024·No. 1:21-cv-00245·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

GRACO INC., GRACO MINNESOTA : CIVIL ACTION INC. : : v. : NO. 21-245 : CARLISLE CONSTRUCTION : MATERIALS, LLC :

MEMORANDUM

MURPHY, J. October 7, 2024

This case involves the infringement of U.S. patent no. 7,527,172 and several counterclaims, including invalidity of the 172 patent, inequitable conduct, and Walker Process antitrust claims. The technology is foam insulation spray guns, which both Carlisle and Graco make and sell. We recently denied several dispositive motions related to the Walker Process claims. DI 456-57. That brings us to two patent-related motions: Carlisle’s motion for summary judgment of no infringement (DI 329), and Graco’s motion for partial summary judgment and supplemental claim construction (DI 335). Both are mostly denied, but granted in part, and the case remains set for trial on December 2, 2024. Carlisle’s motion argues that there is no infringement as a matter of law because claims 1 and 10 of the 172 patent require admission passages tangent to the cylindrical sidewall of the spray gun’s mixing chamber, and the accused ST1 spray gun’s passages are not tangent. Graco concedes that proving literal infringement is “functionally implausible” under the established construction of “tangent,” but argues that the ST1 gun infringes under the doctrine of equivalents because the admission passages are offset from tangent by a negligible distance. DI 378 at 1-2. Graco asserts that a jury could find equivalence based on the evidence and expert testimony it has proffered. Id. Graco further argues that even though “tangent” was added by amendment, prosecution history estoppel does not foreclose equivalents because the reason for the amendment that swept in the tangent limitation bore only “a tangential relation to the equivalent in question.”1 Id. (quoting Pharma Tech Sols., Inc. v. LifeScan, Inc., 942 F.3d 1372, 1380 (Fed. Cir. 2019)).

Graco’s motion asks us to construe the claim term “two parts” in claim 1 (and, equivalently, “two-part” in claim 10). DI 338 at 1-2. Claim construction is in the rear-view mirror in this case, but O2 Micro and a spirit of determination among lawyers tend to make objects closer than they may appear. Id. (citing O2 Micro Int’l Ltd. v. Beyond Innovation Tech. Co. Ltd., 521 F.3d 1351, 1362 (Fed. Cir. 2008)). Graco proposes the construction “two separate pieces” and argues that if we agree, then the claims will exclude the prior art Probler 1 drawings as a matter of law. And if Probler 1 is out, so goes Carlisle’s inequitable conduct and Walker Process claims because they require the materiality of Probler 1. Id. (citing Therasense, Inc. v. Becton, Dickinson & Co., 649 F.3d 1276, 1291-92 (Fed. Cir. 2011)). Graco asks us to construe “two parts” under both the Phillips and the broadest reasonable interpretation (BRI) standards

because the Phillips construction is relevant to validity and infringement, while the BRI standard is relevant to the inequitable conduct and Walker Process claims. Graco argues that its construction “two separate pieces” is appropriate under both Phillips and BRI. Id. Carlisle responds that Graco has failed to demonstrate a claim construction dispute that warrants a construction of “two parts.” DI 372 at 6-9. Carlisle also argues that Graco’s proposed claim construction is an attempt to inject the requirement that the “two parts” be

1 Yes, we will be analyzing the “tangential-relation” exception for the claim term “tangent.” Patent law truly delivers. 2 separable after assembly (i.e., not just “separate” but “separable”), and that if we do construe “two parts” under Phillips, the construction should at most be “formed from two or more pieces of material.” Id. at 9-13. Carlisle argues further that Graco’s proposed construction does not yield summary judgment on the inequitable conduct and antitrust claims because, among other

reasons, the Probler 1 drawings would be material to patentability under 35 U.S.C. § 103, if not 35 U.S.C. § 102. Id. at 17-19. For the reasons discussed in more detail below, both motions are GRANTED IN PART. We grant summary judgment of no literal infringement but deny summary judgment of no infringement by equivalents. We construe the claim term “two parts” to mean “two separate pieces,” but we deny summary judgment on the inequitable conduct and antitrust claims. The analysis below will first address the issues surrounding infringement by equivalents, then address the claim construction of “two parts,” and lastly address whether summary judgment is appropriate for the inequitable conduct and antitrust claims. I. Legal Standard

Summary judgment is proper only when “there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a). “A factual dispute is genuine if the evidence is such that a reasonable jury could return a verdict for the nonmoving party” and “[w]e view all the facts in the light most favorable to the nonmoving party and draw all inferences in that party’s favor.” Physicians Healthsource, Inc. v. Cephalon, Inc., 954 F.3d 615, 618 (3d Cir. 2020) (internal quotations omitted). “When the parties present a fundamental dispute regarding the scope of a claim term, it is the court’s duty to resolve it.” O2 Micro, 521 F.3d at 1362. We “may engage in claim

3 construction during various phases of litigation, not just in a Markman order.” Conoco, Inc. v. Energy & Env't Int'l, L.C., 460 F.3d 1349, 1359 (Fed. Cir. 2006). II. Analysis A. There is no literal infringement as a matter of law but equivalents will pass to the jury. The parties agree that Carlisle’s ST1 spray gun does not literally infringe any claim in the 172 patent. DI 330 at 4-5; DI 378 at 1. Because there are no asserted disputes of material facts regarding literal infringement, we will grant summary judgment on this claim for Carlisle. The parties disagree about whether a dispute of material fact exists related to Graco’s claim of infringement under the doctrine of equivalents.

i. The tangential-relation exception to prosecution history estoppel applies here. A patent owner may rely upon the doctrine of equivalents to encompass “insubstantial alterations that were not captured in drafting the original patent claim but which could be created through trivial changes.” Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 535 U.S. 722, 733 (2002). Prosecution history estoppel prevents a patent owner from recapturing through equivalents claim scope surrendered during the prosecution of a patent. “Estoppel arises when an amendment is made to secure the patent and the amendment narrows the patent’s scope” and that amendment was made for a “substantial reason related to patentability.” Id. at 735-36. A narrowing amendment made to secure the patent gives rise to a presumption of estoppel, but that presumption can be rebutted if: “(1) the rationale underlying the amendment bears no more than a tangential relation to the equivalent in question; (2) the equivalent was unforeseeable at the time of the application; or (3) there was some other reason suggesting that the patentee could not reasonably be expected to have described the equivalent.” Bio-Rad 4 Labs.,2 Inc. v.

Free access — add to your briefcase to read the full text and ask questions with AI

Graco Inc. v. Carlisle Construction Materials, LLC, (D. Del. 2024).

Graco Inc. v. Carlisle Construction Materials, LLC (Graco Inc. v. Carlisle Construction Materials, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Beacon Theatres, Inc. v. Westover
359 U.S. 500 (Supreme Court, 1959)
Warner-Jenkinson Co. v. Hilton Davis Chemical Co.
520 U.S. 17 (Supreme Court, 1997)
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
535 U.S. 722 (Supreme Court, 2002)
Intervet Inc. v. Merial Limited
617 F.3d 1282 (Federal Circuit, 2010)
Rothman v. Target Corp.
556 F.3d 1310 (Federal Circuit, 2009)
Shum v. Intel Corp.
499 F.3d 1272 (Federal Circuit, 2007)
Therasense, Inc. v. Becton, Dickinson and Co.
649 F.3d 1276 (Federal Circuit, 2011)
Cabinet Vision and Larry Cornwell v. Cabnetware
129 F.3d 595 (Federal Circuit, 1997)
In Re Baker Hughes Incorporated
215 F.3d 1297 (Federal Circuit, 2000)
Brilliant Instruments, Inc. v. Guidetech, LLC.
707 F.3d 1342 (Federal Circuit, 2013)
Facebook, Inc. v. Pragmatus Av, LLC
582 F. App'x 864 (Federal Circuit, 2014)
Microsoft Corporation v. Proxyconn, Inc.
789 F.3d 1292 (Federal Circuit, 2015)
TransWeb, LLC v. 3M Innovative Properties Co.
812 F.3d 1295 (Federal Circuit, 2016)
In Re: Csb-System International, Inc.
832 F.3d 1335 (Federal Circuit, 2016)
Regeneron Pharmaceuticals, Inc. v. Merus N.V.
864 F.3d 1343 (Federal Circuit, 2017)